Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

Sesame Care vs Gala Health

Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.

WinnerGrade B+ · #4

Sesame Care

An established national telehealth marketplace with the widest real brand-name GLP-1 access on the board — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.

Visit Sesame Care
vs
Grade B · #8

Gala Health

One of the few names on the board that pairs a genuinely cheap compounded entry with a real brand-Ozempic path and nationwide coverage — the verdict docks it only for a sky-high brand sticker and an oral route it doesn't yet offer.

Visit Gala Health

The verdict

Winner: Sesame Care

Sesame Care takes it with a higher Verdict Score — 87/100 to 86/100 (grade B+ vs B). Shoppers who want genuine FDA-approved brand-name GLP-1s and the ability to pick their own provider and see the price up front, rather than one fixed compounded program. Gala Health still earns its place — patients in any state who want to start on low-cost compounded tirzepatide but keep a legitimate brand-name option on the table.

Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

86Real-world results85
80Price honesty87
92Prescriber access88
95Formulary choice88
82Cancellation fairness84
80Member support84

Price, coverage & features

MetricSesame CareGala Health
Verdict Score87/10086/100
GradeB+B
SemaglutideFrom $149/mo (brand Wegovy pill)Not disclosed
TirzepatideBrand Zepbound (price varies)$179/mo
CoverageNationwide marketplaceAll 50 states
Brand-name accessYesYes
Oral / sublingualYesNo

Sesame Care

What we like

  • Real FDA-approved brand-name access — Wegovy pen and pill, Zepbound, Ozempic, Mounjaro and Rybelsus
  • Established platform (operating since 2018) with LegitScript, BBB accreditation and large third-party review volume
  • You choose the provider and see the price up front — genuine marketplace transparency
  • Oral routes available (Wegovy pill, Rybelsus)

The caveats

  • A generalist marketplace, not a dedicated weight-loss program — lighter ongoing hand-holding than a specialist desk
  • Two-part cost (a platform subscription plus the medication) makes the true monthly total harder to compare
  • Brand-name cash prices can run high without insurance

Gala Health

What we like

  • Low compounded entry — tirzepatide at $179/mo, microdose at $149/mo, and a 3-month plan from $199/mo
  • Available in all 50 states, so access never blocks the sign-up
  • Offers a real FDA-approved brand path (Ozempic) alongside the compounded track — rare on this list
  • Adjacent HRT and menopause care for patients who want more than a GLP-1 alone

The caveats

  • GLP-1 is compounded, not FDA-approved — the standard verification caveat applies
  • Brand Ozempic runs $1,299/mo — the brand path exists but is priced out of reach for most
  • No oral or sublingual option yet
  • Newer operator (AI Coaching Inc) with a thin public track record — vet the pharmacy yourself

Our pick — visit

Shoppers who want genuine FDA-approved brand-name GLP-1s and the ability to pick their own provider and see the price up front, rather than one fixed compounded program.

Visit Sesame Care Read the full Sesame Care review →

Also worth a look

Patients in any state who want to start on low-cost compounded tirzepatide but keep a legitimate brand-name option on the table.

Visit Gala Health Read the full Gala Health review →

Keep comparing

Or browse the full comparison hub and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.